Your browser doesn't support javascript.
loading
Age-stratified risk of unexpected uterine sarcoma following surgery for presumed benign leiomyoma.
Brohl, Andrew S; Li, Li; Andikyan, Vaagn; Obican, Sarah G; Cioffi, Angela; Hao, Ke; Dudley, Joel T; Ascher-Walsh, Charles; Kasarskis, Andrew; Maki, Robert G.
Afiliação
  • Brohl AS; Icahn Institute for Genomics and Multiscale Biology, Department of Genetics and Genomic Sciences, Division of Hematology and Medical Oncology, Department of Medicine, and Department of Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, New York, USA;
  • Li L; Icahn Institute for Genomics and Multiscale Biology, Department of Genetics and Genomic Sciences, Division of Hematology and Medical Oncology, Department of Medicine, and Department of Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, New York, USA;
  • Andikyan V; Icahn Institute for Genomics and Multiscale Biology, Department of Genetics and Genomic Sciences, Division of Hematology and Medical Oncology, Department of Medicine, and Department of Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, New York, USA;
  • Obican SG; Icahn Institute for Genomics and Multiscale Biology, Department of Genetics and Genomic Sciences, Division of Hematology and Medical Oncology, Department of Medicine, and Department of Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, New York, USA;
  • Cioffi A; Icahn Institute for Genomics and Multiscale Biology, Department of Genetics and Genomic Sciences, Division of Hematology and Medical Oncology, Department of Medicine, and Department of Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, New York, USA;
  • Hao K; Icahn Institute for Genomics and Multiscale Biology, Department of Genetics and Genomic Sciences, Division of Hematology and Medical Oncology, Department of Medicine, and Department of Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, New York, USA;
  • Dudley JT; Icahn Institute for Genomics and Multiscale Biology, Department of Genetics and Genomic Sciences, Division of Hematology and Medical Oncology, Department of Medicine, and Department of Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, New York, USA;
  • Ascher-Walsh C; Icahn Institute for Genomics and Multiscale Biology, Department of Genetics and Genomic Sciences, Division of Hematology and Medical Oncology, Department of Medicine, and Department of Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, New York, USA;
  • Kasarskis A; Icahn Institute for Genomics and Multiscale Biology, Department of Genetics and Genomic Sciences, Division of Hematology and Medical Oncology, Department of Medicine, and Department of Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, New York, USA;
  • Maki RG; Icahn Institute for Genomics and Multiscale Biology, Department of Genetics and Genomic Sciences, Division of Hematology and Medical Oncology, Department of Medicine, and Department of Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, New York, USA;
Oncologist ; 20(4): 433-9, 2015 Apr.
Article em En | MEDLINE | ID: mdl-25765878
BACKGROUND: Estimates of unexpected uterine sarcoma following surgery for presumed benign leiomyoma that use age-stratification are lacking. PATIENTS AND METHODS: A retrospective cohort of 2,075 patients that had undergone myomectomy was evaluated to determine the case incidence of unexpected uterine sarcoma. An aggregate risk estimate was generated using a meta-analysis of similar studies plus our data. Database-derived age distributions of the incidence rates of uterine sarcoma and uterine leiomyoma surgery were used to stratify risk by age. RESULTS: Of 2,075 patients in our retrospective cohort, 6 were diagnosed with uterine sarcoma. Our meta-analysis revealed 8 studies from 1980 to 2014. Combined with our study, 18 cases of leiomyosarcoma are reported in 10,120 patients, for an aggregate risk of 1.78 per 1,000 (95% confidence interval [CI]: 1.1-2.8) or 1 in 562. Eight cases of other uterine sarcomas were reported in 6,889 patients, for an aggregate risk of 1.16 per 1,000 (95% CI: 0.5-4.9) or 1 in 861. The summation of these risks gives an overall risk of uterine sarcoma of 2.94 per 1,000 (95% CI: 1.8-4.1) or 1 in 340. After stratification by age, we predict the risk of uterine sarcoma to range from a peak of 10.1 cases per 1,000, or 1 in 98, for patients aged 75-79 years to <1 case per 500 for patients aged <30 years. CONCLUSION: The risk of unexpected uterine sarcoma varies significantly across age groups. Our age-stratified predictive model should be incorporated to more accurately counsel patients and to assist in providing guidelines for the surgical technique for leiomyoma.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma / Neoplasias Uterinas / Leiomioma Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma / Neoplasias Uterinas / Leiomioma Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article